UTHR- United Therapeutics Corporation

Name: United Therapeutics Corporation Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

United Therapeutics Corporation (UTHR) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 108 sells. UTHR is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Rothblatt Martine A	66.0K	$35.41M	-
VP	Mahon Paul A	44.5K	$23.88M	-
CEO	Rothblatt Martine A	40.5K	$21.74M	-28,500
VP	Mahon Paul A	33.5K	$17.98M	-
CFO	Edgemond James	19.9K	$10.67M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 16, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$549.80	$5,223,068.48	-2.1%	-	-
Jun 8, 2026	Edgemond James	CFO And Treasurer	Sale+OE	10,000	$547.50	$5,475,044.88	-5.4%	-	-
Jun 1, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$547.91	$5,205,104.61	-2.4%	-	-
Jun 1, 2026	Edgemond James	CFO And Treasurer	Sale+OE	10,000	$547.87	$5,478,663.35	-4.9%	-	-
May 29, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$553.83	$5,261,365.38	-1.7%	-	-
May 12, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$578.38	$5,494,562.96	-1.5%	-	-
Apr 27, 2026	Edgemond James	CFO And Treasurer	Sale+OE	10,000	$568.83	$5,688,318.95	-5.8%	-	-
Apr 20, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$577.83	$5,489,423.82	-1.5%	-	-
Apr 20, 2026	Edgemond James	CFO And Treasurer	Sale+OE	10,000	$577.86	$5,778,606.91	-3.3%	-	-
Mar 16, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$537.81	$5,109,148.28	-16.5%	+2.2%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC